Skip to main content

Efficacy of ERYSENG® PARVO/LEPTO on swine farms with leptospirosis problems

Publications
Swine
Authors

Scherer, C.; Puig, A.; Camprodon, A.; Coll, M.; Cesio, M.; March, R.

Appeared in

IPVS Congress, 2016

Vaccination with ERYSENG® PARVO LEPTO was shown to be

efficacious against leptospira infections by a reduction in the

percentage of abortions, a reduction in the number of stillborn and

mummies per litter and a reduction in leptospira infections in the

vaccinated animals.

Leptospirosis is a cause of reproductive loss in breeding herds and has been reported in swine from all parts of the world. When it is first introduced into a susceptible breeding herd, or during periods of waning herd immunity, it can cause very appreciable losses through abortion, or the full-term birth of dead pigs, or weak pigs of reduced viability or infertility. ERYSENG® PARVO/LEPTO is a new octavalent combined parvovirus, erysipelas and leptospira vaccine adjuvanted with HIPRAMUNE® Gd. The objective of this study was to assess the efficacy of the ERYSENG® PARVO/LEPTO vaccine on swine farms with reproductive problems due to leptospirosis.

Download this article
PDF